Atlas Trials

Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple Sclerosis

Clinical trial NCT07756268 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07756268
Sponsor
Tongji Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2026-09-16
Primary completion
2029-02-07
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.